206 related articles for article (PubMed ID: 19273690)
1. Violacein extracted from Chromobacterium violaceum inhibits Plasmodium growth in vitro and in vivo.
Lopes SC; Blanco YC; Justo GZ; Nogueira PA; Rodrigues FL; Goelnitz U; Wunderlich G; Facchini G; Brocchi M; Duran N; Costa FT
Antimicrob Agents Chemother; 2009 May; 53(5):2149-52. PubMed ID: 19273690
[TBL] [Abstract][Full Text] [Related]
2. Cysteamine, the natural metabolite of pantetheinase, shows specific activity against Plasmodium.
Min-Oo G; Ayi K; Bongfen SE; Tam M; Radovanovic I; Gauthier S; Santiago H; Rothfuchs AG; Roffê E; Sher A; Mullick A; Fortin A; Stevenson MM; Kain KC; Gros P
Exp Parasitol; 2010 Aug; 125(4):315-24. PubMed ID: 20219464
[TBL] [Abstract][Full Text] [Related]
3. Synergy of human immunodeficiency virus protease inhibitors with chloroquine against Plasmodium falciparum in vitro and Plasmodium chabaudi in vivo.
He Z; Qin L; Chen L; Peng N; You J; Chen X
Antimicrob Agents Chemother; 2008 Jul; 52(7):2653-6. PubMed ID: 18443126
[TBL] [Abstract][Full Text] [Related]
4. A chloroquine-like molecule designed to reverse resistance in Plasmodium falciparum.
Burgess SJ; Selzer A; Kelly JX; Smilkstein MJ; Riscoe MK; Peyton DH
J Med Chem; 2006 Sep; 49(18):5623-5. PubMed ID: 16942036
[TBL] [Abstract][Full Text] [Related]
5. Synergy of the antiretroviral protease inhibitor indinavir and chloroquine against malaria parasites in vitro and in vivo.
Li X; He Z; Chen L; Li Y; Li Q; Zhao S; Tao Z; Hu W; Qin L; Chen X
Parasitol Res; 2011 Dec; 109(6):1519-24. PubMed ID: 21537980
[TBL] [Abstract][Full Text] [Related]
6. Chloroquine resistant Plasmodium falciparum in migrant population.
Srivastava HC; Sharma SK
Indian J Malariol; 2000; 37(1-2):39-42. PubMed ID: 11820081
[No Abstract] [Full Text] [Related]
7. Short report: effects of pyronaridine on gametocytes in patients with acute uncomplicated falciparum malaria.
Ringwald P; Meche FS; Basco LK
Am J Trop Med Hyg; 1999 Sep; 61(3):446-8. PubMed ID: 10497988
[TBL] [Abstract][Full Text] [Related]
8. BDA-410: a novel synthetic calpain inhibitor active against blood stage malaria.
Li X; Chen H; Jeong JJ; Chishti AH
Mol Biochem Parasitol; 2007 Sep; 155(1):26-32. PubMed ID: 17583361
[TBL] [Abstract][Full Text] [Related]
9. The effect of chloroquine on the production of interferon-gamma, interleukin (IL)-4, IL-6, and IL-10 in Plasmodium chabaudi chabaudi in infected C57BL6 mice.
Rosa R; Silveira H; Seixas E; Rolão N; Santos-Gomes G; do Rosário V
J Parasitol; 1999 Oct; 85(5):956-60. PubMed ID: 10577734
[TBL] [Abstract][Full Text] [Related]
10. Exploring the antimalarial potential of whole Cymbopogon citratus plant therapy.
Chukwuocha UM; Fernández-Rivera O; Legorreta-Herrera M
J Ethnopharmacol; 2016 Dec; 193():517-523. PubMed ID: 27693771
[TBL] [Abstract][Full Text] [Related]
11. Plasmodium chabaudi chabaudi malaria parasites can develop stable resistance to atovaquone with a mutation in the cytochrome b gene.
Afonso A; Neto Z; Castro H; Lopes D; Alves AC; Tomás AM; Rosário VD
Malar J; 2010 May; 9():135. PubMed ID: 20492669
[TBL] [Abstract][Full Text] [Related]
12. Differential sensitivity of erythrocytic stages of the rodent malaria parasite Plasmodium chabaudi chabaudi to dioncophylline B, a highly active naphthylisoquinoline alkaloid.
François G; Chimanuka B; Timperman G; Holenz J; Plaizier-Vercammen J; Aké Assi L; Bringmann G
Parasitol Res; 1999 Nov; 85(11):935-41. PubMed ID: 10540956
[TBL] [Abstract][Full Text] [Related]
13. Curcumin for malaria therapy.
Reddy RC; Vatsala PG; Keshamouni VG; Padmanaban G; Rangarajan PN
Biochem Biophys Res Commun; 2005 Jan; 326(2):472-4. PubMed ID: 15582601
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the sensitivity in vitro of Plasmodium falciparum and in vivo of Plasmodium chabaudi Malaria to various drugs and their combinations.
Rahman NN
Med J Malaysia; 1997 Dec; 52(4):390-8. PubMed ID: 10968116
[TBL] [Abstract][Full Text] [Related]
15. In vivo responses to antimalarials by Plasmodium falciparum and Plasmodium vivax from isolated Gag Island off northwest Irian Jaya, Indonesia.
Fryauff DJ; Sumawinata I; Purnomo ; Richie TL; Tjitra E; Bangs MJ; Kadir A; Ingkokusumo G
Am J Trop Med Hyg; 1999 Apr; 60(4):542-6. PubMed ID: 10348226
[TBL] [Abstract][Full Text] [Related]
16. The A/T-specific DNA alkylating agent adozelesin inhibits Plasmodium falciparum growth in vitro and protects mice against Plasmodium chabaudi adami infection.
Yanow SK; Purcell LA; Spithill TW
Mol Biochem Parasitol; 2006 Jul; 148(1):52-9. PubMed ID: 16597469
[TBL] [Abstract][Full Text] [Related]
17. Sequence polymorphisms in pfcrt are strongly associated with chloroquine resistance in Plasmodium falciparum.
Chen N; Russell B; Staley J; Kotecka B; Nasveld P; Cheng Q
J Infect Dis; 2001 May; 183(10):1543-5. PubMed ID: 11319698
[No Abstract] [Full Text] [Related]
18. Indolone-N-oxide derivatives: in vitro activity against fresh clinical isolates of Plasmodium falciparum, stage specificity and in vitro interactions with established antimalarial drugs.
Tahar R; Vivas L; Basco L; Thompson E; Ibrahim H; Boyer J; Nepveu F
J Antimicrob Chemother; 2011 Nov; 66(11):2566-72. PubMed ID: 21862474
[TBL] [Abstract][Full Text] [Related]
19. Quinoline antimalarials containing a dibemethin group are active against chloroquinone-resistant Plasmodium falciparum and inhibit chloroquine transport via the P. falciparum chloroquine-resistance transporter (PfCRT).
Zishiri VK; Joshi MC; Hunter R; Chibale K; Smith PJ; Summers RL; Martin RE; Egan TJ
J Med Chem; 2011 Oct; 54(19):6956-68. PubMed ID: 21875063
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the stage-specific efficacy of chloroquine, artemether and dioncophylline B against the rodent malaria parasite Plasmodium chabaudi chabaudi in vivo.
Chimanuka B; François G; Timperman G; Heyden YV; Holenz J; Plaizier-Vercammen J; Bringmann G
Parasitol Res; 2001 Oct; 87(10):795-803. PubMed ID: 11688884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
